XIAOMI-W
01810
BABA-W
09988
ALI HEALTH
00241
KUAISHOU-W
01024
BIDU-SW
09888
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 28.50%974.49M | 16.18%1.52B | 19.36%758.33M | -58.02%1.31B | -64.55%635.32M | -13.16%3.12B | 0.75%1.79B | -6.46%3.6B | -1.80%1.78B | 6.40%3.85B |
Operating income | 28.50%974.49M | 16.18%1.52B | 19.36%758.33M | -58.02%1.31B | -64.55%635.32M | -13.16%3.12B | 0.75%1.79B | -6.46%3.6B | -1.80%1.78B | 6.40%3.85B |
Cost of sales | -39.71%-754.14M | -20.14%-1.07B | -20.49%-539.8M | 61.04%-889.82M | 62.92%-448.01M | 4.39%-2.28B | -0.90%-1.21B | 4.05%-2.39B | 2.00%-1.2B | -6.79%-2.49B |
Operating expenses | -39.71%-754.14M | -20.14%-1.07B | -20.49%-539.8M | 61.04%-889.82M | 62.92%-448.01M | 4.39%-2.28B | -0.90%-1.21B | 4.05%-2.39B | 2.00%-1.2B | -6.79%-2.49B |
Gross profit | 0.83%220.35M | 7.82%454.16M | 16.67%218.54M | -49.81%421.22M | -67.92%187.31M | -30.51%839.33M | 0.43%583.94M | -10.89%1.21B | -1.40%581.43M | 5.69%1.36B |
Selling expenses | -15.02%-1.98M | 57.50%-4.66M | 55.98%-1.72M | 57.48%-10.96M | 74.76%-3.9M | -52.14%-25.78M | -136.25%-15.47M | 73.06%-16.94M | 70.04%-6.55M | -4.69%-62.88M |
Administrative expenses | -14.75%-113.11M | -15.73%-255.68M | -24.44%-98.57M | 44.27%-220.94M | 57.98%-79.21M | 6.03%-396.41M | -0.27%-188.5M | -2.07%-421.84M | 1.45%-188M | -9.98%-413.29M |
Employee expense | ---- | ---- | ---- | ---- | ---- | 6.24%82.95M | -13.77%34.67M | -3.65%78.07M | 0.78%40.21M | 1.29%81.03M |
Revaluation surplus | -75.98%-1.39M | -67.34%-1.5M | -327.72%-787K | 93.07%-897K | -110.27%-184K | -425.60%-12.94M | 360.70%1.79M | -344.63%-2.46M | 25.08%-687K | -88.90%1.01M |
-Changes in the fair value of investment property | -75.98%-1.39M | -67.34%-1.5M | -327.72%-787K | 93.07%-897K | -110.27%-184K | -425.60%-12.94M | 360.70%1.79M | -344.63%-2.46M | 25.08%-687K | -88.90%1.01M |
Impairment and provision | 28.98%-33.21M | 11.00%-130.53M | 39.83%-46.77M | 73.08%-146.67M | -483.57%-77.73M | -510.03%-544.81M | 44.14%-13.32M | -3.03%-89.31M | 18.97%-23.85M | -65.34%-86.68M |
-Other impairment is provision | 28.98%-33.21M | 11.00%-130.53M | 39.83%-46.77M | 73.08%-146.67M | -483.57%-77.73M | -510.03%-544.81M | 44.14%-13.32M | -3.03%-89.31M | 18.97%-23.85M | -65.34%-86.68M |
Operating interest expense | ---- | ---- | ---- | ---- | 95.81%-4.04M | -33.89%-281.69M | -9.55%-96.37M | -4.30%-210.39M | 20.12%-87.97M | 32.55%-201.71M |
Special items of operating profit | 128.33%8.48M | -157.30%-13.67M | -472.12%-29.94M | -94.06%23.86M | -80.01%8.05M | 166.01%401.44M | 22.38%40.25M | 411.54%150.91M | 7.61%32.89M | -60.71%29.5M |
Operating profit | 94.17%79.15M | -26.66%48.12M | 34.55%40.76M | 5.68%65.62M | -91.27%30.3M | -91.08%62.09M | -0.14%346.99M | -0.94%695.8M | 13.16%347.48M | 6.54%702.41M |
Financing cost | -51.59%-1.24M | 65.39%-1.89M | ---816K | ---5.46M | ---- | ---- | ---- | ---- | ---- | ---- |
Share of profits of associates | -85.00%105K | 211.97%1.54M | 976.92%700K | -46.88%493K | -94.87%65K | -76.43%928K | 321.26%1.27M | -0.03%3.94M | 108.09%301K | 2,392.41%3.94M |
Share of profit from joint venture company | -728.59%-31.6M | -24.44%4.84M | 219.58%5.03M | 170.00%6.41M | 194.93%1.57M | -1,019.08%-9.15M | 73.04%-1.66M | -89.94%996K | -183.04%-6.15M | -5.82%9.9M |
Earning before tax | 1.63%46.42M | -21.54%52.61M | 43.03%45.67M | 24.50%67.06M | -90.79%31.93M | -92.31%53.86M | 1.46%346.61M | -2.17%700.73M | 9.94%341.63M | 6.91%716.25M |
Tax | -10.26%-13.31M | -5.96%-19.65M | -37.37%-12.08M | 47.10%-18.54M | 90.56%-8.79M | 77.91%-35.05M | 2.37%-93.13M | 12.12%-158.68M | -25.86%-95.39M | -18.86%-180.56M |
After-tax profit from continuing operations | -1.47%33.1M | -32.05%32.97M | 45.18%33.6M | 157.86%48.52M | -90.87%23.14M | -96.53%18.82M | 2.94%253.47M | 1.19%542.06M | 4.81%246.24M | 3.41%535.69M |
Earning after tax | -1.47%33.1M | -32.05%32.97M | 45.18%33.6M | 157.86%48.52M | -90.87%23.14M | -96.53%18.82M | 2.94%253.47M | 1.19%542.06M | 4.81%246.24M | 3.41%535.69M |
Minority profit | 202.99%8.72M | -41.96%9.96M | -54.56%2.88M | 1,379.31%17.16M | 91.54%6.34M | -97.12%1.16M | -66.23%3.31M | 8.66%40.33M | -48.60%9.8M | 12.47%37.12M |
Profit attributable to shareholders | -20.64%24.38M | -26.63%23.01M | 82.78%30.72M | 77.61%31.36M | -93.28%16.81M | -96.48%17.66M | 5.80%250.17M | 0.63%501.72M | 9.52%236.44M | 2.79%498.57M |
Basic earnings per share | -20.77%0.0164 | -26.54%0.0155 | 83.19%0.0207 | 77.31%0.0211 | -93.43%0.0113 | -96.59%0.0119 | 3.49%0.172 | -4.33%0.349 | 2.28%0.1662 | -3.75%0.3648 |
Diluted earnings per share | -20.77%0.0164 | -26.54%0.0155 | 83.19%0.0207 | 77.31%0.0211 | -93.43%0.0113 | -96.59%0.0119 | 3.49%0.172 | -4.33%0.349 | 2.28%0.1662 | -3.72%0.3648 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Pak Chun Certified Public Accountants Limited | -- | Pak Chun Certified Public Accountants Limited | -- | Pak Chun Certified Public Accountants Limited | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.